Jinling Hospital, China

This trial investigates whether ursodeoxycholic acid (UDCA), a bile acid medication, can protect kidney function in adults undergoing partial nephrectomy for kidney cancer. During surgery, blood flow to the kidney is temporarily stopped, which can cause injury. Participants take …

This study tests whether people with advanced kidney cancer can safely pause their medication after one year of treatment. Doctors will use a special PET scan that targets CD70 to decide who qualifies for a treatment break. The goal is to see if patients can stop drugs without th…

This study tests whether semaglutide, a drug used for diabetes, can improve intestinal barrier function in adults with short bowel syndrome who need intravenous nutrition. Twenty participants will receive either semaglutide or a placebo for 28 days. Researchers will measure blood…

This phase 2 trial is testing whether giving two drugs—toripalimab and lenvatinib—before and after surgery can improve outcomes for people with clear cell renal cell carcinoma. The study enrolls 75 patients with different stages of kidney cancer. Participants receive the drugs fo…

This study compares two ways to reach a blood clot in the basilar artery, a key vessel at the back of the brain, during a stroke. One method uses the femoral artery in the groin, the other uses the radial artery in the wrist. Researchers want to see which approach leads to better…

This study tests a safe, non-drug treatment called remote ischemic preconditioning (RIC) to see if it can stop early neurological decline in people who have had a mild stroke caused by a blocked small artery. The treatment involves briefly inflating a blood pressure cuff on the a…

This study tests whether using a low-sodium, potassium-enriched salt substitute instead of regular salt can help protect kidney function in people who have had surgery for a kidney tumor. Two hundred adults who had a partial or full kidney removal will either use the salt substit…

This study looks at how well the drug vorolanib works for people with advanced kidney cancer that cannot be removed by surgery or has spread. It is for patients who need a second treatment after their first one stopped working. The study will track how long the cancer stays under…

This phase 2 trial is testing whether PET/CT scans can safely guide treatment pauses in people with advanced kidney cancer. Participants who have responded well to at least 12 months of standard therapy (immunotherapy plus targeted drugs) will stop treatment and be monitored with…

This phase 2 trial is testing a combination of high-dose and low-dose radiotherapy, plus an immunotherapy drug, in 35 people with kidney cancer that got worse after prior immunotherapy. The goal is to see if this approach can control the disease and how safe it is. Participants w…

This study tests whether an artificial intelligence (AI) model can help doctors find brain aneurysms more accurately on CT scans. Over 6,400 adults in China will have their scans reviewed by radiologists with either a real AI or a sham AI that gives no real help. The goal is to s…

This study looks at two different ways to keep patients comfortable and calm during a procedure to remove a blood clot from the brain after a stroke. The goal is to find out which method helps patients recover better and have fewer problems. About 810 adults having this emergency…

This study is testing whether two advanced ultrasound techniques—contrast-enhanced ultrasound and super-resolution imaging—can predict how well a person's kidneys will recover after surgery for kidney cancer. Researchers will scan the kidneys before and after surgery and track ki…

This study looks at whether a simple blood test that finds bits of tumor DNA can help doctors monitor kidney cancer after surgery. Researchers will follow 450 people who have just been diagnosed with kidney cancer and are having surgery to remove it. The goal is to see if the blo…